Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Dean Foods Announces Resignation of WhiteWave Foods President Steve Demos
Steve Demos has resigned his position as President of the Company's WhiteWave Foods with Dean Foods Chairman and Chief Executive Officer, Gregg Engles, assuming direct leadership over WhiteWave Foods on an interim basis.
- Dean Foods Announces Resignation of WhiteWave Foods President Steve Demos
Steve Demos has resigned his position as President of the Company's WhiteWave Foods with Dean Foods Chairman and Chief Executive Officer, Gregg Engles, assuming direct leadership over WhiteWave Foods on an interim basis.
- Dean Foods Announces Resignation of WhiteWave Foods President Steve Demos
Steve Demos has resigned his position as President of the Company's WhiteWave Foods with Dean Foods Chairman and Chief Executive Officer, Gregg Engles, assuming direct leadership over WhiteWave Foods on an interim basis.
- AMS Health Sciences Announces 2004 Year-End Financial Results
Company reports net sales of $18.5 million for FY04 compared to $18.5 million prior year; 2004 net loss reported at $6.3 million, or $(0.90) per common and diluted share, compared to a net loss of $2.6 million, or $(0.57) per common and diluted share in 2003.
- AMS Health Sciences Announces 2004 Year-End Financial Results
Company reports net sales of $18.5 million for FY04 compared to $18.5 million prior year; 2004 net loss reported at $6.3 million, or $(0.90) per common and diluted share, compared to a net loss of $2.6 million, or $(0.57) per common and diluted share in 2003.
- E.T. Horn Company Selected By Loders Croklaan as Exclusive Distributor of SensoryEffects(TM) Products in Western States
Company signs distribution agreement with Loders Croklaan to represent its line of SensoryEffects(TM) inclusions throughout the western United States.
- E.T. Horn Company Selected By Loders Croklaan as Exclusive Distributor of SensoryEffects(TM) Products in Western States
Company signs distribution agreement with Loders Croklaan to represent its line of SensoryEffects(TM) inclusions throughout the western United States.
- Natrol Announces 2004 Results
Company reports net income of $1.9 million or $0.13 per diluted share compared to a net loss of $1.5 million or $0.11 per share prior year; net sales for 2004 rose 9.1%, from $72.7 million to $79.3 million.
- Natrol Announces 2004 Results
Company reports net income of $1.9 million or $0.13 per diluted share compared to a net loss of $1.5 million or $0.11 per share prior year; net sales for 2004 rose 9.1%, from $72.7 million to $79.3 million.
- Enzymotec Targets South-East Asia Functional Oils Market
Company declares intention of penetrating functional oils market of South-East Asia and Western Pacific.
- Enzymotec Targets South-East Asia Functional Oils Market
Company declares intention of penetrating functional oils market of South-East Asia and Western Pacific.
- EuroPharma and Enzymatic Therapy Sign Licensing and Distribution Agreement
Enzymatic Therapy to take over marketing, sales and dsitribution of Europharma's SneezEze and Renouvelle products.
- EuroPharma and Enzymatic Therapy Sign Licensing and Distribution Agreement
Enzymatic Therapy to take over marketing, sales and dsitribution of Europharma's SneezEze and Renouvelle products.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- SourceOne(TM) Announces Joint Venture Agreement with American River Nutrition
Company to provide marketng and sales to scientific support, product development and manufacturing contribution of American River Nutrition.
- SourceOne(TM) Announces Joint Venture Agreement with American River Nutrition
Company to provide marketng and sales to scientific support, product development and manufacturing contribution of American River Nutrition.
- Nutritional Laboratories International Signs Equity Deal with Red Diamond Capital
Company finalizes a deal with private equity firm Red Diamond Capital.
- Nutritional Laboratories International Signs Equity Deal with Red Diamond Capital
Company finalizes a deal with private equity firm Red Diamond Capital.
- Glykon Technologies Group Ends HCA Licensing Agreement with Renaissance Herbs
Company has terminated its licensing agreement with Renaissance Herbs, Inc. covering uses and delivery systems for (–)-hydroxycitric acid and related products, effective February 4, 2005.
- Glykon Technologies Group Ends HCA Licensing Agreement with Renaissance Herbs
Company has terminated its licensing agreement with Renaissance Herbs, Inc. covering uses and delivery systems for (–)-hydroxycitric acid and related products, effective February 4, 2005.
- ACNielsen and SPINS Expand Coverage of Fast-Growing Natural Products Industry
Companies announce expansion of SPINSscan Conventional information service tracking sales of natural and organic products across grocery, drug, and mass merchandise retail outlets; For the first time, retailer-specific analysis of natural and organic product sales will be available from the service, and the number of categories tracked will nearly double.
- ACNielsen and SPINS Expand Coverage of Fast-Growing Natural Products Industry
Companies announce expansion of SPINSscan Conventional information service tracking sales of natural and organic products across grocery, drug, and mass merchandise retail outlets; For the first time, retailer-specific analysis of natural and organic product sales will be available from the service, and the number of categories tracked will nearly double.
- Reliv International Announces Executive Promotion
Company announces that Steven D. Albright has been promoted to the office of Vice President and Chief Financial Officer, replacing David Kreher who will be continuing his employment with the company as Director of Special Projects.
- Reliv International Announces Executive Promotion
Company announces that Steven D. Albright has been promoted to the office of Vice President and Chief Financial Officer, replacing David Kreher who will be continuing his employment with the company as Director of Special Projects.
- Reliv International Announces Executive Promotion
Company announces that Steven D. Albright has been promoted to the office of Vice President and Chief Financial Officer, replacing David Kreher who will be continuing his employment with the company as Director of Special Projects.
- Reliv International Announces Executive Promotion
Company announces that Steven D. Albright has been promoted to the office of Vice President and Chief Financial Officer, replacing David Kreher who will be continuing his employment with the company as Director of Special Projects.
- Renaud Beauchesne, President and CEO of Advitech To Present At BioMatch 2005
Renaud Beauchesne, President and CEO of Advitech Inc. will be a presenter at BioMatch 2005, which will be held on March 31, 2005, at the Fairmount-Queen Elizabeth in Montreal.
- Renaud Beauchesne, President and CEO of Advitech To Present At BioMatch 2005
Renaud Beauchesne, President and CEO of Advitech Inc. will be a presenter at BioMatch 2005, which will be held on March 31, 2005, at the Fairmount-Queen Elizabeth in Montreal.
- Renaud Beauchesne, President and CEO of Advitech To Present At BioMatch 2005
Renaud Beauchesne, President and CEO of Advitech Inc. will be a presenter at BioMatch 2005, which will be held on March 31, 2005, at the Fairmount-Queen Elizabeth in Montreal.
- Renaud Beauchesne, President and CEO of Advitech To Present At BioMatch 2005
Renaud Beauchesne, President and CEO of Advitech Inc. will be a presenter at BioMatch 2005, which will be held on March 31, 2005, at the Fairmount-Queen Elizabeth in Montreal.
- CortDev, Inc. Signs Letter of Intent to Acquire Botaniex Inc.
As part of the agreement, CDVJ will acquire 100% of the outstanding shares and assets of Botaniex Inc. in exchange for an equity position in CDVJ.
- CortDev, Inc. Signs Letter of Intent to Acquire Botaniex Inc.
As part of the agreement, CDVJ will acquire 100% of the outstanding shares and assets of Botaniex Inc. in exchange for an equity position in CDVJ.
- Natural Health Trends Corp. Announces Fiscal 2004 Results
Company reports Q4 sales of $36.3 million compared to $22.6 million prior year; records net loss of approximately $802,000, or a loss of $0.12 per fully diluted share, versus net income of $1.1 million, or $0.19 per fully diluted share previous year. The decrease in net income was due to higher commissions paid to distributors and selling, general and administrative expenses.
- Natural Health Trends Corp. Announces Fiscal 2004 Results
Company reports Q4 sales of $36.3 million compared to $22.6 million prior year; records net loss of approximately $802,000, or a loss of $0.12 per fully diluted share, versus net income of $1.1 million, or $0.19 per fully diluted share previous year. The decrease in net income was due to higher commissions paid to distributors and selling, general and administrative expenses.
- COOLBRANDS Appoints New Independent Director, Approves Final Breyer's Financing
Company appoints Arthur Waldbaum to serve as a Director; Board approves $40 million in financing for the previously announced acquisition of Breyer's yogurt from Kraft Foods; transaction expected to close March 28, 2005.
- COOLBRANDS Appoints New Independent Director, Approves Final Breyer's Financing
Company appoints Arthur Waldbaum to serve as a Director; Board approves $40 million in financing for the previously announced acquisition of Breyer's yogurt from Kraft Foods; transaction expected to close March 28, 2005.
- COOLBRANDS Appoints New Independent Director, Approves Final Breyer's Financing
Company appoints Arthur Waldbaum to serve as a Director; Board approves $40 million in financing for the previously announced acquisition of Breyer's yogurt from Kraft Foods; transaction expected to close March 28, 2005.
- COOLBRANDS Appoints New Independent Director, Approves Final Breyer's Financing
Company appoints Arthur Waldbaum to serve as a Director; Board approves $40 million in financing for the previously announced acquisition of Breyer's yogurt from Kraft Foods; transaction expected to close March 28, 2005.
- AMS Health Sciences Launches Retail Merchant Division
Retail Merchant Division will sell AMS products through health food stores, spas, gyms, privately owned drug and herb shops, as well as to alternative health practices.
- AMS Health Sciences Launches Retail Merchant Division
Retail Merchant Division will sell AMS products through health food stores, spas, gyms, privately owned drug and herb shops, as well as to alternative health practices.
- Stephen A. Block, Esq. Joins the Board of Directors of Senomyx, Inc.
Stephen A. Block, Esq., former Senior Vice President, General Counsel and Secretary of International Flavors & Fragrances, Inc., has joined the Company's Board of Directors.
- Stephen A. Block, Esq. Joins the Board of Directors of Senomyx, Inc.
Stephen A. Block, Esq., former Senior Vice President, General Counsel and Secretary of International Flavors & Fragrances, Inc., has joined the Company's Board of Directors.
- Stephen A. Block, Esq. Joins the Board of Directors of Senomyx, Inc.
Stephen A. Block, Esq., former Senior Vice President, General Counsel and Secretary of International Flavors & Fragrances, Inc., has joined the Company's Board of Directors.
- Stephen A. Block, Esq. Joins the Board of Directors of Senomyx, Inc.
Stephen A. Block, Esq., former Senior Vice President, General Counsel and Secretary of International Flavors & Fragrances, Inc., has joined the Company's Board of Directors.
- Reliv International Names Managing Director for U.K./Ireland Operations
Company has named Eric J. Vill as the company's new Managing Director for its operations in the United Kingdom and Ireland.
- Reliv International Names Managing Director for U.K./Ireland Operations
Company has named Eric J. Vill as the company's new Managing Director for its operations in the United Kingdom and Ireland.
- Reliv International Names Managing Director for U.K./Ireland Operations
Company has named Eric J. Vill as the company's new Managing Director for its operations in the United Kingdom and Ireland.
- Reliv International Names Managing Director for U.K./Ireland Operations
Company has named Eric J. Vill as the company's new Managing Director for its operations in the United Kingdom and Ireland.
- Gateway Announces International Distribution
Company is in the process of negotiating and signing export and wholesale distribution contracts for a period of 5 years with companies in the health & dietary supplements operating in China, Hong Kong and Indonesia.
- Gateway Announces International Distribution
Company is in the process of negotiating and signing export and wholesale distribution contracts for a period of 5 years with companies in the health & dietary supplements operating in China, Hong Kong and Indonesia.
- New Zealand Milk becomes Fonterra Brands
Company's consumer business, New Zealand Milk, is to be renamed Fonterra Brands.
- New Zealand Milk becomes Fonterra Brands
Company's consumer business, New Zealand Milk, is to be renamed Fonterra Brands.
- AEterna Zentaris Subsidiary Atrium Biotechnologies Files Final Prospectus for $75 Million Initial Public Offering (CDN)
Subsidiary Atrium Biotechnologies Inc. has filed prospectus in connection with an initial public offering and secondary offering of 6,250,000 subordinate voting shares at a price of $12 per share, for total proceeds of $75 million. (CDN)
- AEterna Zentaris Subsidiary Atrium Biotechnologies Files Final Prospectus for $75 Million Initial Public Offering (CDN)
Subsidiary Atrium Biotechnologies Inc. has filed prospectus in connection with an initial public offering and secondary offering of 6,250,000 subordinate voting shares at a price of $12 per share, for total proceeds of $75 million. (CDN)
- Forbes Medi-Tech Announces Financial Results for the 4th Quarter and Year Ended
Company reports revenue of $5.76 million for Q4 compared to $3.93 million prior year; reports total revenue of $17.6 million for FY04, versus $14.3 for 2003, net loss of $0.25 per share for the year.
- Forbes Medi-Tech Announces Financial Results for the 4th Quarter and Year Ended
Company reports revenue of $5.76 million for Q4 compared to $3.93 million prior year; reports total revenue of $17.6 million for FY04, versus $14.3 for 2003, net loss of $0.25 per share for the year.
- Lifeway Foods Reports Year End Results
Company reports sales up 9.7% from $14,878,000 to $16,319,000; Net income was $2,052,000, or 24 cents a share, compared to $2,222,000, or 26 cents a share, for 2003.
- Lifeway Foods Reports Year End Results
Company reports sales up 9.7% from $14,878,000 to $16,319,000; Net income was $2,052,000, or 24 cents a share, compared to $2,222,000, or 26 cents a share, for 2003.
- Pure World Announces Results for 2004
Company reports net income of $635,000 ($.08 per share) compared to revenues of $21,890,000 with a net loss of $245,000 ($.03 per share) in 2003.
- Pure World Announces Results for 2004
Company reports net income of $635,000 ($.08 per share) compared to revenues of $21,890,000 with a net loss of $245,000 ($.03 per share) in 2003.
- Hovid Bhd – Carotech’s Parent Company Enroute to IPO on the Malaysian Securities Exchange Board
Hovid Bhd, the parent company of Carotech Inc, has announced an initial public offering of 24,177,000 shares and made a public issue of 12,800,000 shares at RM1.76 each.
- Hovid Bhd – Carotech’s Parent Company Enroute to IPO on the Malaysian Securities Exchange Board
Hovid Bhd, the parent company of Carotech Inc, has announced an initial public offering of 24,177,000 shares and made a public issue of 12,800,000 shares at RM1.76 each.
- Allergy Research Group, Inc. Reports 2004 Results
Company reports FY04 net income after tax of $1,282,736 versus $1,643,770 prior year, with revenues of $15,136,592, up 11% over 2003.
- Allergy Research Group, Inc. Reports 2004 Results
Company reports FY04 net income after tax of $1,282,736 versus $1,643,770 prior year, with revenues of $15,136,592, up 11% over 2003.
- Dynamic Health Products Completes Acquisition of Dynamic Marketing, Inc.
Company completes previously announced acquisition.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
HAIFA, Israel, March 24, 2005 /PRNewswire-FirstCall via COMTEX/ -- Frutarom (LSE: FRUTq, TASE: FRUT) today presented its full year and fourth quarter 2004 results. 2004 was the fifth consecutive year of record results for Frutarom. This year the Company continued its trend of increased sales, profitability and profits following the successful implementation of Frutarom's rapid growth strategy combining organic growth of core activities with strategic acquisitions of activities and knowhow in its main fields of business and in strategic geographic regions.
According to Ori Yehudai, the Frutarom Group's President and Chief Executive Officer, "In 2004 Frutarom made further significant progress in positioning itself as one of the world's leading flavors and fragrances companies. The excellent results that Frutarom achieved are due to the double digit organic growth in core activities (as achieved in previous years), the successful integration of the Flachsmann activities acquired by Frutarom in 2003; and our focus on leveraging the cross selling possibilities from the recent acquisition of the Food Systems activity from International Flavors & Fragrances, Inc. ("IFF"). The activities and achievements of recent years coupled with the many cross selling opportunities serve as a solid foundation for Frutarom's continued future growth and prosperity.
During the second half of 2004, Frutarom completed the acquisition of IFF's Food Systems activity in Europe. The Food Systems business develops, produces and markets unique compounds of fruit and other natural ingredients used in a wide variety of food products. This acquisition significantly expanded Frutarom's multinational food and beverage customer base; geographic reach in Europe, including entry to new countries; and its product portfolio, including new and unique products that integrate flavors, natural functional food ingredients and food systems. Additionally, the acquisition strengthened Frutarom's savory flavor offering, which is a growing segment of the food industry, and which Frutarom will focus on strengthening. Frutarom estimates that the acquisition will leverage and strengthen its position as a leading global supplier to the food industry, offering natural, comprehensive solutions to leading food manufacturers, including a broad and innovative range of products for the functional food industry.
During the fourth quarter of 2004 the first phase of the integration of the Food System activity with Frutarom's existing activities ended, including transferring the production activity previously conducted by IFF in France to Frutarom's Food Systems production sites in Switzerland and Germany, and the integration of Frutarom's existing Food Systems activity in England. In addition, the sales and marketing and research and development teams in Europe were fully integrated. Following the completion of this first phase, Frutarom started the second phase of leveraging the many cross selling opportunities between the new customers and products and Frutarom's existing customers and products.
According to Yehudai, "In 2004, Frutarom's management completed a strategic planning process so as to redefine the Company's vision, goals and strategy for the coming years, which will materially strengthen our position as a leading global company. The Company's management has set a revenues target of US$ 500 - 600 million for 2008. This goal will be achieved by continuing to implement our rapid growth strategy of recent years, which includes accelerated growth in core activities, above-industry average growth, and by executing strategic acquisitions. Frutarom will continue to focus on both large multinational customers and on mid size and local customers by providing superior, high quality tailor-made service. Frutarom will persevere in strengthening its presence in developed markets, Western Europe and the United States, and intensify its activities in fast growing emerging markets where it currently operates, as well as entering additional countries. The Company will continue to offer a broad product portfolio consisting largely of natural products and new innovative products such as functional food ingredients."
Frutarom's sales(1) in 2004 totaled US$ 196.8 million, a 41.2% increase compared with 2003, when sales reached US$ 139.3 million. Gross profit during the period rose by 49.1% to reach US$ 74.3 million compared with US$ 49.9 million last year. Gross margin grew from 35.8% to 37.8%. Operating profit grew sharply by 75.2% to US$ 22 million compared with US$ 12.6 million in 2003, while operating margin improved to 11.2% compared with 9.0% last year. Net profit grew significantly by 96.1% to US$ 15.8 million compared with US$ 8 million in 2003. Net margin also grew from 5.8% in 2003 to 8.0% in 2004.
Yehudai emphasized that the growth in sales is impressive, particularly in comparison to the industry's average annual growth rates, ranging from 2% to 4%. In 2004 the growth in the Flavors Division's sales, which typically generate higher margins than fine ingredients products, as a proportion of Frutarom's total sales reached 56.4% this year (compared with 42.1% in 2002). The Fine Ingredients Division grew through its continued focus on developing innovative value-added products with higher than average margin. The ongoing improvement in efficiencies and synergies also contributed to the growth.
In 2004, Frutarom achieved a cash flow from operations of US$ 17.3 million compared with US$ 10.1 million in 2003. The cash flow was used to reduce debt, finance investments and grow the Company's cash balances.
Frutarom's equity as at December 31, 2004 totaled US$ 78.7 million, which is 36.8% of the balance sheet, compared with US$ 59.6 million as at December 31, 2003, or 42.4% of the balance sheet. The growth comes largely from the profit for the period.
During the fourth quarter, Frutarom's sales totaled US$ 56.9 million, up 51.0% compared with the fourth quarter of 2003, when sales reached US$ 37.7 million. Gross profit for the quarter rose by 52.6% to reach US$ 20.2 million. Operating profit rose sharply by 246% to total US$ 4.3 million, with gross margin reaching 7.5% compared with 3.3% during the same quarter in 2003. The fourth quarter's net profit also grew significantly by 275.7%, to total US$ 3.0 million compared with US$ 0.8 million in 2003. Net margin also rose sharply to reach 5.3% compared with 2.1% last year.
Frutarom's activity is characterized by seasonal fluctuations, generally with higher sales and profitability during the first half of the year and lower sales and margin during the second half. The impact of seasonality on the Company's results has steadily decreased in recent years as the Company has increased its sales of products such as savory flavors, functional food ingredients and natural pharma/nutraceutical extracts, which generally have lower seasonality in demand. The especially cold and wet summer that hit Europe in 2004 harmed the sales of some Frutarom customers (mainly in beverages and ice cream). Nevertheless, Frutarom was still able to succeed in growing all of its core activities during the second half of the year.
Yehudai concluded, "Frutarom's management invests considerable resources in identifying and executing potential acquisitions and in achieving rapid growth in core activities to ensure that value is created for our shareholders. During the first quarter of 2005, Frutarom completed a US$ 75.8 million (net) offering and registration of shares on the London Stock Exchange Official List. This offering added leading international investors to the Frutarom shareholder portfolio and strengthened our global position. The proceeds will be used largely to finance future strategic acquisitions as part of the implementation of Frutarom's strategy".
Background on the Company
Frutarom is a global company with significant production and development centers on three continents, which markets its product to over 3,500 customers in more than 100 countries worldwide. Frutarom's products are intended largely for the food, beverage, flavor, fragrance and pharmaceutical industries.
Frutarom operates through two Divisions:
- The Flavors Division, which develops, produces and markets flavors and food systems
- The Fine Ingredients Division, which develops, produces and markets raw materials intended mainly for the production of flavors, fragrances, plant extracts and natural products, including medicinal extracts.
Frutarom is also active in several innovative activities, including through its ArtChem activity, which develops, produces and markets raw materials in the peptide field, intended for the pharmaceutical industry producing through biotechnological methods.
Frutarom's products are produced at its plants in the United States, England, Switzerland, Germany, Israel, Denmark, China, and Turkey. The Company's global marketing organization includes branches in Israel, the United States, England, Switzerland, Germany, Denmark, France, Hungary, Romania, Russia, Ukraine, Kazakhstan, Belarus, Turkey, Brazil, Mexico, China, Japan, Hong Kong and India. The Company also works through local agents and distributors worldwide. Frutarom employs about 1,000 people worldwide. |